Mumbai has emerged as a significant hub for pharmaceutical creation, with several firms specializing in the creation of Active Pharmaceutical Ingredients (APIs). Notably, a number of prominent enterprises are focused on the manufacture of Finasteride API (CAS No: 98319-26-7), meeting the global dema